. 2022 Apr 12;17(4):e0261165. doi: 10.1371/journal.pone.0261165

Table 2. Summary of data available for individual clinical outcome measures^a.

	ACR20_W6	RD28_W6	ΔDAS28_W6	ΔDAS28_W12
Total	362	347	344	339
CZP	302	287	287	284
Placebo	60	60	57	55

ACR20_W6, 20% reduction in ACR at week 6; RD28_W6, reduction in DAS28 at week 6 (dichotomous phenotype); ΔDAS28_W6, change in DAS28 at week 6; ΔDAS28_W12, change in DAS28 at week 12.

^aIncomplete outcome data available for DAS28.

Table 2. Summary of data available for individual clinical outcome measuresa.

Table 2. Summary of data available for individual clinical outcome measures^a.